Study of feasibility and acceptability of screen and treat approach for cervical cancer prevention

Kirandeep Kaur; Amrit Pal Kaur; Permeet Kaur Bagga; Jyothi

doi:10.18203/2320-6012.ijrms20243712

Authors

Kirandeep Kaur Department of Obstetrics and Gynaecology, Government Medical College, Amritsar, Punjab, India
Amrit Pal Kaur Department of Obstetrics and Gynaecology, Government Medical College, Amritsar, Punjab, India
Permeet Kaur Bagga Department of Pathology, Government Medical College, Amritsar, Punjab, India
Jyothi Department of Obstetrics and Gynaecology, Government Medical College, Amritsar, Punjab, India

DOI:

https://doi.org/10.18203/2320-6012.ijrms20243712

Keywords:

VIA, Thermocoagulation, Cervical cancer

Abstract

Background: Cervical cancer is the fourth most prevalent cancer among women globally, with approximately 604,000 new cases and 342,000 deaths reported Worldwide according to GLOBOCAN 2022. In India, cervical cancer ranks as the second most common cancer cervical cancer accounts for 6-29% of all malignancies in women in India. Most patients with cervical cancer in India are diagnosed at an advanced stage. Cervical cancer is both preventable and curable if detected early through proper screening.

Methods: The present study is a prospective study of 1 year which included 500 patients between age 30-50 years, selected after verifying inclusion and exclusion criteria. All the women were screened using VIA and underwent treatment with thermocoagulation. Immediate side effects and side effects at 3 and 6 monthly follow up visits were noted.

Results: In this study, a total of 500 women participated. The VIA positivity rate was 11.4%., 94.7% women underwent thermocoagulation. The mean VAS score for pain was 3.815±0.772. During 3 monthly followup visit, 25.92% females reported discharge per vaginum. No side effects were reported at 6 month follow up visit. The case detection rate was 6.4%. The positive predictive value (PPV) was 59.2%.

Conclusions: VIA is an excellent alternative to cytology and other expensive screening methods in resource-limited settings like ours. Similarly, thermocoagulation is a quick and straightforward procedure to perform. Utilizing VIA for screening and thermocoagulation as a treatment method has high acceptability among patients, with no significant side effects, making it a safe treatment option.

Metrics

Metrics Loading ...

References

Canfell K. Towards the global elimination of cervical cancer. Papillomavirus Res. 2019;8:100170.

Moshi JM, Sohaili A, Moafa HN, Hakami AM, Mashi MM, Thomas PP. Understanding the Barriers to Cervical Cancer Prevention and HPV Vaccination in Saudi Arabia. Viruses. 2024;16(6):974.

Deo SV, Sharma J, Kumar S. GLOBOCAN 2020 report on global cancer burden: challenges and opportunities for surgical oncologists. Ann Surg Oncol. 2022;29(11):6497-500.

Bobdey S, Sathwara J, Jain A, Balasubramaniam G. Burden of cervical cancer and role of screening in India. Ind J Med Paed Oncol. 2016;37(04):278-85.

Mohammed SI, Ren W, Flowers L, Rajwa B, Chibwesha CJ, Parham GP, et al. Point-of-care test for cervical cancer in LMICs. Oncotarget. 2016;7(14):18787.

Singla S, Mathur S, Kriplani A, Agarwal N, Garg P, Bhatla N. Single visit approach for management of cervical intraepithelial neoplasia by visual inspection and loop electrosurgical excision procedure. Ind J Med Res. 2012;135(5):614-20.

Alliance for Cervical Cancer Prevention. New evidence on the impact of cervical cancer screening and treatment using HPV DNA tests, visual inspection, or cytology. Cervical Cancer Prevention Fact Sheet. 2009.

Denny L. Cervical cancer: Prevention and treatment. Discov Med. 2012;14(75):125-31.

Naud PS, Muwonge R, Passos EP, Magno V, Matos J, Sankaranarayanan R. Efficacy, safety, and acceptability of thermocoagulation for treatment of cervical intraepithelial neoplasia in a hospital setting in Brazil. Int J Gynecol Obst. 2016;133(3):351-4.

Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, et al. Cancer incidence and mortality worldwide: IARC. Cancer Base. 2012(11):18-22.

Wilailak S, Kengsakul M, Kehoe S. Worldwide initiatives to eliminate cervical cancer. Int J Gynecol Obstet. 2021;155:102-6.

Rijal P, Pradhan T, Agrawal A, Rai R, Bhatta R, Chhetri S. Assessment of Risk Factors, Feasibility and Acceptability of VIA for Cervical Cancer Screening and Prevention. Nepal J Obst Gynaecol. 2016;11(1):50-4.

Viviano M, Kenfack B, Catarino R, Tincho E, Temogne L, Benski AC, et al. Feasibility of thermocoagulation in a screen-and-treat approach for the treatment of cervical precancerous lesions in sub-Saharan Africa. BMC Womens Health. 2017;17(1):2.

Campbell C, Kafwafwa S, Brown H, Walker G, Madetsa B, Deeny M, et al. Use of thermo‐coagulation as an alternative treatment modality in a ‘screen‐and‐treat’programme of cervical screening in rural Malawi. Int J Cancer. 2016;139(4):908-15.

Lee F, Bula A, Chapola J, Mapanje C, Phiri B, Kamtuwange N, et al. Women’s experiences in a community-based screen-and-treat cervical cancer prevention program in rural Malawi: a qualitative study. BMC Cancer. 2021;21(1):428.

Vet JN, Kooijman JL, Henderson FC, Aziz FM, Purwoto G, Susanto H, et al. Single-visit approach of cervical cancer screening: see and treat in Indonesia. Br J Cancer. 2012;107(5):772-7.